Exact Sciences shares rose to 55.10▲ 10.49 (23.51%) After Hours
#GH’s test 83% sensitivity in detecting individuals with colorectal cancer;
Exact Sciences’s in January test Cologuard showed overall sensitivity of 95.2% in detecting colorectal cancer.
Guardant Health wrecked after hours after announces
results from a study using its blood test to screen for colorectal #cancer that didn’t appear to surpass Exact Sciences’ stool-sample screening test.
$GH down 40.0%